Can B | 10-Q: Q3 2024 Earnings Report
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Can B&S Group S.A. (AMS:BSGR) Maintain Its Strong Returns?
Can B&M European Value Retail S.A.'s (LON:BME) ROE Continue To Surpass The Industry Average?
AI in Email Marketing: How Can B2B Marketers Take Advantage
Can B | 10-Q: Q2 2024 Earnings Report
GenAI Is Fundamentally Altering Content Creation - How Can B2B Marketers Respond?
Can B.C.'s Southern Resident Orcas Be Taken off the Path to Extinction?
Can B | 10-Q/A: Quarterly report (Amendment)
Canadian CanadaBis Reports C$3.97M Net Revenue In Q3 2024, 26% Decline YoY
Can B | 10-Q: Q1 2024 Earnings Report
Can B Secures Ownership of Two Cannabis Patents Valued at $122M
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
Can B Secures 1.8M Pounds of Biomass for Awarded Contract With One Bad Moon Rising
CanadaBis Capital's Fiscal Q3 Profit, Net Revenue Grows; Provides Outlook
Can B GAAP EPS of -$4.18, Revenue of $6.7M
Can B Corp. FY22 Revenue Grows 45% To $6.7M, Here Are The Details
CanadaBis Capital Says Intends to Introduce More Products in 2023, Expects Sales Growth to Continue
CanadaBis Capital Swings to Q1 Net Income From Year-Ago Loss; Net Revenue $5.15 Million Vs $1.85 Million
Can B GAAP EPS of -$1.98, Revenue of $2.9M
No Data
No Data